Jacqueline P. Ernest

Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing

Maria Garcia‐Cremades, Belén P. Solans, Emma Hughes et al. · Clinical Pharmacology & Therapeutics · 2020 · 112 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Discovery of novel brain permeable and G protein-biased beta-1 adrenergic receptor partial agonists for the treatment of neurocognitive disorders

Bitna Yi, Alam Jahangir, Andrew K. Evans et al. · PLoS ONE · 2017 · 33 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

A Rabbit Model to Study Antibiotic Penetration at the Site of Infection for Nontuberculous Mycobacterial Lung Disease: Macrolide Case Study

Firat Kaya, Jacqueline P. Ernest, Katherine LoMauro et al. · Antimicrobial Agents and Chemotherapy · 2022 · 21 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimen

Natasha Strydom, Jacqueline P. Ernest, Marjorie Z. Imperial et al. · Nature Communications · 2024 · 17 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs

Jacqueline P. Ernest, Janice Jia Ni Goh, Natasha Strydom et al. · European Respiratory Journal · 2023 · 16 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17